Innovel Intelligent Technology

Suzhou, China Founded: 2018 • Age: 8 yrs
Bioreactors and automated systems for cell culture production are supplied.
Annual revenue - Latest available
Total funding $15.3M 1 rounds
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Innovel Intelligent Technology

Innovel Intelligent Technology is a company based in Suzhou (China) founded in 2018. Innovel Intelligent Technology has raised $15.28 million across 1 funding round. Innovel Intelligent Technology operates in a competitive market with competitors including Limula, PBS Biotech, m2p-labs, Membio and Bionet Engineering, among others.

  • Headquarter Suzhou, China
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $15.28 M (USD)

    in 1 rounds

  • Latest Funding Round
    $15.28 M (USD), Series A

    Mar 29, 2021

  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Innovel Intelligent Technology

Innovel Intelligent Technology has successfully raised a total of $15.28M through 1 strategic funding round. The most recent funding activity was a Series A round of $15.28 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investments & Acquisitions by Innovel Intelligent Technology

Investments
Premium access

Investment portfolio details for Innovel Intelligent Technology

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Innovel Intelligent Technology

Premium access

Detailed financials for Innovel Intelligent Technology

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Innovel Intelligent Technology Comparisons

Innovel Intelligent Technology Primary company
Description
Bioreactors and automated systems for cell culture productio...
Location
Suzhou, China
Founded Year
2018
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Innovel Intelligent Technology

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Innovel Intelligent Technology

Innovel Intelligent Technology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Limula, PBS Biotech, m2p-labs, Membio and Bionet Engineering, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Modular solutions for on-demand cell therapy manufacturing are provided.
Locked Locked Locked
Developer of single-use bioreactors for the production of vaccines, therapeutic proteins, and cell therapies
Locked Locked Locked
Micro-bioreactors are provided for screening and bioprocess development.
Locked Locked Locked
Developer of single-use bioreactors for cell and gene therapies
Locked Locked Locked
Manufactures bioreactors, TFF systems, and software for biopharma and agri-food applications.
Locked Locked Locked
Contract research and discovery services are provided to biopharma firms.
Premium access

Detailed competitors of Innovel Intelligent Technology

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Innovel Intelligent Technology

Premium access

Complete news archive for Innovel Intelligent Technology

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Innovel Intelligent Technology

Innovel Intelligent Technology was founded in 2018 and raised its 1st funding round 3 years after it was founded.

Innovel Intelligent Technology is headquartered in Suzhou, China. It is registered at Suzhou, Jiangsu, China.

Innovel Intelligent Technology is a funded company, having raised a total of $15.28M across 1 funding round to date.

Provider of bioreactors for cell culture. The company has developed an automatic system ImmunoBase and InnoFluid for the production of biological drugs and industrial-scale production, testing, and storage. IMMUNOBASE is new series of bioreactors without agitating paddles for laboratories and large-scale production and InnoFluid is a research-grade liquid circulating perfusion reactor for the production of antibodies, viruses, and cells. The company has also developed ImmunoVessel made of breathable membrane technology that optimizes the breathability of the culture bottle, ImmunoDuct to enhance virus transduction efficiency, and InnoIncubator is a fully automatic high-efficiency incubator for large-scale cultivation of cell products.

Innovel Intelligent Technology's top competitors include PBS Biotech, m2p-labs and Limula.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available